The human body naturally produces growth hormones in the pituitary gland, which stimulate growth and cell regeneration. Growth hormone is stored and secreted by somatotropic cells in the anterior pituitary gland. Excessive secretion of growth hormones can lead to the development of a benign pituitary tumor consisting of somatotroph cells, which produce an excess of growth hormones.
The Human Growth Hormone Market is being driven by new mergers and acquisitions and a strong pipeline. Additionally, the market is being boosted by a high prevalence of growth hormone deficiency, with over 10,000 children and 50,000 adults affected in the US alone. However, strict regulations banning the use of human growth hormone by athletes and sports professionals by the FDA and the International Olympic Committee are expected to limit the growth of the market.
Leading Companies in the Human Growth Hormone Industry:
1. Pfizer Inc.
Pfizer Inc. was established in 1849 and is headquartered in New York, United States. It operates in 181 countries and is engaged in various industries, including biotechnology, healthcare, medical, and pharmaceuticals. In 2021, Pfizer and OPKO announced the extension of the biologics license application for somatrogon for growth hormone deficiency.
2. Novo Nordisk
Novo Nordisk was established in 1923 and is headquartered in Bagsværd, Denmark. It operates in over 170 countries and is engaged in various industries, including biotechnology, healthcare, medical, and pharmaceuticals. In 2023, Novo Nordisk developed a new drug molecule called Somapacitan for treating growth hormones.
3. Merck & Co.
Merck & Co. was established in 1891 and is headquartered in Rahway, New Jersey, United States. It operates in over 191 countries and is engaged in developing medicines, vaccines, biologic therapies, and animal health products. In 2021, Merck KGaA signed up with PRA Health Sciences to wed its human growth hormone (HGH) treatment system with the CRO’s remote patient monitoring platform. In 2021, Merck developed a specific version for applications in the field of human growth hormone. The device keeps track of patients’ HGH daily injections and monitors adherence to their treatment plan.